New drug combo shows promise in early cancer trial
NCT ID NCT07226349
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new experimental drug called BG-75098, given alone or with other medicines, in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. About 105 participants will take part in this early-phase trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Blacktown Cancer and Haematology Centre
RECRUITINGBlacktown, New South Wales, NSW 2148, Australia
-
Cabrini Hospital Malvern
RECRUITINGMalvern, Victoria, VIC 3144, Australia
-
Cancer Hospital Chinese Academy of Medical Sciences
RECRUITINGBeijing, Beijing Municipality, 100021, China
-
Genesiscare St Leonards
RECRUITINGSt Leonards, New South Wales, NSW 2065, Australia
-
Harbin Medical University Cancer Hospital
RECRUITINGHarbin, Heilongjiang, 150000, China
-
Icon Cancer Centre Wesley
RECRUITINGAuchenflower, Queensland, QLD 4066, Australia
-
Jiangsu Province Hospital Longjiang Branch
RECRUITINGNanjing, Jiangsu, 210036, China
-
Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226-1222, United States
-
Next Houston
RECRUITINGHouston, Texas, 77054, United States
-
One Clinical Research
RECRUITINGNedlands, Western Australia, WA 6009, Australia
-
Peter Maccallum Cancer Centre
RECRUITINGMelbourne, Victoria, VIC 3000, Australia
-
Qilu Hospital of Shandong University
RECRUITINGJinan, Shandong, 250000, China
-
Rigshospitalet
RECRUITINGCopenhagen, 2100, Denmark
-
Sidney Kimmel Comprehensive Cancer At Johns Hopkins
RECRUITINGBaltimore, Maryland, 21287, United States
-
Sun Yat Sen Memorial Hospital, Sun Yat Sen University (South)
RECRUITINGGuangzhou, Guangdong, 510245, China
-
The University of Texas Md Anderson Cancer Center
RECRUITINGHouston, Texas, 77030-4009, United States
-
Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, 430030, China
-
Union Hospital Tongji Medical College Huazhong University of Science and Technologyjinyinhu Branch
RECRUITINGWuhan, Hubei, 430048, China
-
University of Alabama At Birmingham Hospital
RECRUITINGBirmingham, Alabama, 35294-0004, United States
-
Weifang Peoples Hospital
RECRUITINGWeifang, Shandong, 261000, China
-
Yale Cancer Center
RECRUITINGNew Haven, Connecticut, 06510, United States